Bill Texts: US HB2855 | 2019-2020 | 116th Congress

Bill Title: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2019-05-21 - Referred to the Subcommittee on Health. [HB2855 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2019-05-21PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB2855

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB2855 currently on file.

feedback